Autopsy report · NCT00040469

Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies

“accrual was slow and sporadic so the study was closed”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 10 months after it had already started.
• Ran for about 3 years 3 months before it stopped.
• 15 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Baylor College of Medicine

Sponsor type

University, hospital or other

Conditions

Sickle Cell Anemia; Hemoglobinopathy; Thalassemia

Interventions

Campath -1H; Dilantin; Busulfan; Cyclophosphamide

Participants

15

Sites

2

Countries

United States

Trials that died the same way

• Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation
  “The study was closed for slow accrual” (93% match in meaning)
• Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer
  “Study was closed to low accrual.” (88% match in meaning)
• High Dose Rate Brachyablation of Primary Liver Lesions
  “Study was closed due to poor accrual” (87% match in meaning)
• S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery
  “This study was closed early due to poor accrual” (87% match in meaning)
• Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer
  “The study was closed to enrollment due to slow accrual.” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.